PTC Therapeutics | PTCT - Pre Tax Profit


PTC Therapeutics reported $-139.08M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 26.32M 18.28M Dec/2025
Alnylam Pharmaceuticals USD 161.14M 77.83M Dec/2025
Amgen USD 3.92B 2.35B Sep/2025
BioCryst Pharmaceuticals USD -86.95M 73.5M Dec/2024
Biogen USD 557.3M 186.7M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Daiichi Sankyo JPY 106.73B 48.96B Dec/2025
Enanta Pharmaceuticals USD -22.71M 95.08M Dec/2024
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
Gilead Sciences USD 3.64B 1.21B Sep/2025
Incyte USD 389.94M 92.37M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
Karyopharm Therapeutics USD -30.89M 1.16M Dec/2024
Novartis USD 4.2B 335M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
PTC Therapeutics USD -139.08M 116.01M Dec/2025
Puma Biotechnology USD 20.61M 24.76M Sep/2024
Roche Holding CHF 4.79B 3.01B Jun/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025
TG Therapeutics USD 45.09M 19.18M Dec/2025
Ultragenyx Pharmaceutical USD -128M 51.54M Dec/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025
Xencor USD -4.27M 1.76M Dec/2025